Skip to main content

and
  1. No Access

    Article

    Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer

    A phase II clinical trial was performed to evaluate the efficacy and safety of gefitinib on pretreated Chinese female non-small-cell lung cancer (NSCLC) patients. Chinese female patients with locally advanced ...

    **g Deng, Wei Jia Fang, **ao Chen Zhang, Dong ** Wu, Hong Ming Fang in Medical Oncology (2012)